Dicerna Pharmaceuticals, Inc. (NASDAQ: DRNA), a leader in the
development of RNAi-based therapeutics, today announced that the Company
will release its third-quarter 2014 financial results before market open
on Thursday, November 6, 2014.
for Dicerna to Announce Third-Quarter 2014 Financial Results and Host Conference Call on November 6, 2014 investment picks